TokenPost·
Sionna Therapeutics Reports $0.72 Net Loss Per Share for Q3
The figure covers both basic and diluted per-share results. The quarter ended Sept. 30, 2026.
More news
- TokenPostGlobal Fossil CO2 Emissions Projected to Fall 0.4% in 2026
- TokenPostGMX Will End Governance Committee and Move Arbitrum Role to Contributors
- TokenPostUSD/JPY Advances 0.6% to 159.666 in Mixed Global Markets
- The BlockBitcoin ‘ripe for a squeeze’ as options traders raise odds of sub-$70,000 Christmas
- TokenPostAnthropic to Restrict Claude Access for Firms Controlled in Unsupported Regions
- NewsBTCFormer Cointelegraph CEO Joins Phase as Co-Founder and CEO